Safety and Efficacy of Ezetimibe With Low Doses of Simvastatin in Heart Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 6, 2008, Pages 685-688

  Quarta, Candida C ^a   Potena, Luciano ^a   Grigioni, Francesco ^a   Scalone, Antonella ^a   Magnani, Gaia ^a   Coccolo, Fabio ^a   Fallani, Francesco ^a   Russo, Antonio ^a   Branzi, Angelo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN A; EVEROLIMUS; EZETIMIBE; LOW DENSITY LIPOPROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SIMVASTATIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; SIMVASTATIN; TREATMENT OUTCOME;

EID: 43949112921     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.02.014     Document Type: Article

References (25)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 869-879
2. Valantine H.A. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma". Transplantation 76 (2003) 891-899
3. Mehra M.R. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant 6 (2006) 1248-1256
4. Kapadia S., Nissen S., Ziada K., et al. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. J Am Coll Cardiol 38 (2001) 206-213
5. Fellstrom B. Impact and management of hyperlipidemia posttransplantation. Transplantation 70 suppl (2000) SS51-SS57
6. Grigioni F., Carigi S., Potena L., et al. Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. Transplant Proc 38 (2006) 1507-1510
7. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
8. Wenke K., Meiser B., Thiery J., et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 107 (2003) 93-97
9. Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation 96 (1997) 1398-1402
10. Wenke K. Management of hyperlipidaemia associated with heart transplantation. Drugs 64 (2004) 1053-1068
11. Page RL II R.L., Miller G.G., and Lindenfeld J. Drug therapy in the heart transplant recipient. Part IV: Drug-drug interactions. Circulation 111 (2005) 230-239
12. Kosoglou T., Statkevich P., Johnson-Levonas A.O., et al. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 44 (2005) 467-494
13. Patel A.R., Ambrose M.S., Duffy G.A., et al. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients. J Heart Lung Transplant 26 (2007) 281-284
14. Biadi O., Potena L., Fearon W.F., et al. Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. J Heart Lung Transplant 26 (2007) 324-330
15. Zawaideh M.A., Ghishan F.K., and Molmenti E.P. Regulation of cholesterol homeostasis in solid organ transplantation. Transplantation 81 (2006) 316-317
16. Wallace C.K., Stetson S.J., Kucuker S.A., et al. Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients. J Heart Lung Transplant 24 (2005) 46-51
17. Lubitz S.A., Pinney S., Wisnivesky J.P., et al. Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation. J Heart Lung Transplant 26 (2007) 264-272
18. Vrtovec B., Stojanovic I., Radovancevic R., et al. Statin-associated QTc interval shortening as prognostic indicator in heart transplant recipients. J Heart Lung Transplant 25 (2006) 234-236
19. Potena L., Frascaroli G., Grigioni F., et al. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. Circulation 109 (2004) 532-536
20. Piorkowski M., Fischer S., Stellbaum C., et al. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?. J Am Coll Cardiol 49 (2007) 1035-1042
21. Huges S. ENHANCE results yield disappointment for ezetimibe. http://www.theheart.org/article/837243.do Accessed January, 15 2008
22. Kastelein J.J., Sager P.T., de Groot E., et al. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial. Am Heart J 149 (2005) 234-239
23. Bergman A.J., Burke J., Larson P., et al. Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects. J Clin Pharmacol 46 (2006) 321-327
24. Bergman A.J., Burke J., Larson P., et al. Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients. J Clin Pharmacol 46 (2006) 328-336
25. Koshman S.L., Lalonde L.D., Burton I., et al. Supratherapeutic response to ezetimibe administered with cyclosporine. Ann Pharmacother 39 (2005) 1561-1565